TCS launches new version of Connected Clinical Trials Platform Launched at TCS ADD Vantage

MUMBAI : Tata Consultancy Services (TCS) has  released a new version of the Connected Clinical Trials (CCT} platform at the recently concluded TCS ADD Vantage forum in Paris. TCS ADD Vantage is an exclusive forum for the pharma ecosystem that brought together leaders and subject matter experts from several global pharmaceutical companies including four of the top five players, and labelling and smart medication packaging solution providers. Participants discussed industry trends and challenges, and how innovative technology solutions can enable them to become future ready.

CCT is an innovative software-as-a-service (SaaS) platform that enables life sciences companies to significantly transform patient engagement in clinical trials and improve the efficiency and  accountability of the clinical supply process. CCT is part of TCS’ Advahced Drug Development (ADD) suite that offers a wide range of cloud based clinical solutions and services, including clinical data management, metadata management, pharmacovigilance, and data analytics and insights.